Cargando…

Prognostic value of heterogeneous ribonucleoprotein A1 expression and inflammatory indicators for patients with surgically resected hepatocellular carcinoma: Perspectives from a high occurrence area of hepatocellular carcinoma in China

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Ke, Ruisheng, Lv, Lizhi, Li, Jiayan, Zhang, Xiaojin, Yang, Fang, Zhang, Kun, Jiang, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312934/ https://www.ncbi.nlm.nih.gov/pubmed/30655822 http://dx.doi.org/10.3892/ol.2018.9580

Ejemplares similares

Prognostic value of heterogeneous ribonucleoprotein A1 expression and inflammatory indicators for patients with surgically resected hepatocellular carcinoma: Perspectives from a high occurrence area of hepatocellular carcinoma in China
por: Ke, Ruisheng, et al.
Publicado: (2018)

High Expression of Heterogeneous Nuclear Ribonucleoprotein A1 Facilitates Hepatocellular Carcinoma Growth
por: Cao, Ziyi, et al.
Publicado: (2023)

Historical Comparison of Overall Survival after Hepatic Resection for Patients With Large and/or Multinodular Hepatocellular Carcinoma: Erratum
Publicado: (2015)

The diagnostic and prognostic significance of small nuclear ribonucleoprotein Sm D1 aberrantly high expression in hepatocellular carcinoma
por: Wang, Huaxiang, et al.
Publicado: (2022)

miR-185 inhibits cell migration and invasion of hepatocellular carcinoma through CDC42
por: Zhang, Qingjun, et al.
Publicado: (2020)

Erratum: Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma
por: Zhao, Ling-Hao, et al.
Publicado: (2016)

PRMT4 promotes hepatocellular carcinoma progression by activating AKT/mTOR signaling and indicates poor prognosis: Erratum
por: Du, Peng, et al.
Publicado: (2022)

DNA topoisomerase IIα and Ki67 are prognostic factors in patients with hepatocellular carcinoma
por: Cao, Yi, et al.
Publicado: (2017)

Expression of ywhaz and gene regulation network in hepatocellular carcinoma
por: Lin, Yi, et al.
Publicado: (2020)

Erratum for Juvenile Hepatocellular Carcinoma in a Healthy Liver
por: Onishi, Sachiyo, et al.
Publicado: (2022)

Revolutionising hepatocellular carcinoma surveillance: Harnessing contrast-enhanced ultrasound and serological indicators for postoperative early recurrence prediction: Erratum
Publicado: (2023)

Erratum: Management of Hepatocellular Carcinoma: Current Status and Future Directions
Publicado: (2015)

Erratum: Shanghai Score: A Prognostic and Adjuvant Treatment-evaluating System Constructed for Chinese Patients with Hepatocellular Carcinoma after Curative Resection
Publicado: (2017)

Analysis of L-type amino acid transporter in canine hepatocellular carcinoma
Publicado: (2015)

Erratum to the genetic association between type 2 diabetic and hepatocellular carcinomas
Publicado: (2022)

Erratum to atractylodin may induce ferroptosis of human hepatocellular carcinoma cells
Publicado: (2023)

Hepatic Resection as a Safe and Effective Treatment for Hepatocellular Carcinoma Involving a Single Large Tumor, Multiple Tumors, or Macrovascular Invasion: Erratum
Publicado: (2015)

Prognostic value of inflammation-based indices in patients with resected hepatocellular carcinoma
por: Kong, Weihao, et al.
Publicado: (2021)

Erratum to: Factors predicting survival after post-transplant hepatocellular carcinoma recurrence
por: Toso, Christian, et al.
Publicado: (2013)

Erratum to: Regulation of the hypoxic tumor environment in hepatocellular carcinoma using RNA interference
por: Choi, Sung Hoon, et al.
Publicado: (2017)

Erratum to: Hepatocellular carcinoma with extrahepatic blood supply from right renal artery
por: Sohail, Amir Humza, et al.
Publicado: (2021)

Effect of CELSR3 on the Cell Cycle and Apoptosis of Hepatocellular Carcinoma Cells: Erratum
por: Xie, Zucheng, et al.
Publicado: (2022)

Indications of Laparoscopic Repeat Liver Resection for Recurrent Hepatocellular Carcinoma
por: Kinoshita, Masahiko, et al.
Publicado: (2021)

Can indication of hepatic resection for hepatocellular carcinoma patients be expanded?
por: Kubota, Keiichi
Publicado: (2023)

Adjuvant Cytokine-Induced Killer Cell Therapy Improves Disease-Free and Overall Survival in Solitary and Nonmicrovascular Invasive Hepatocellular Carcinoma After Curative Resection: Erratum
Publicado: (2016)

Erratum to: Heregulin-1ß and HER3 in hepatocellular carcinoma: status and regulation by insulin
por: Buta, Corina, et al.
Publicado: (2016)

Erratum to “Durable Objective Response to Sorafenib and Role of Sequential Treatment in Unresectable Hepatocellular Carcinoma”
Publicado: (2022)

Hypoxia-induced up-regulation of VASP promotes invasiveness and metastasis of hepatocellular carcinoma: Erratum
por: Liu, Zhikui, et al.
Publicado: (2023)

Erratum to “miR-876 Inhibits EMT and Liver Fibrosis via POSTN to Suppress Metastasis in Hepatocellular Carcinoma”
por: Chen, Kai, et al.
Publicado: (2020)

Molecular heterogeneity in hepatocellular carcinoma
por: Zhu, Shijia, et al.
Publicado: (2018)

Heterogeneous nuclear ribonucleoprotein K (hnRNP K) is a tissue biomarker for detection of early Hepatocellular carcinoma in patients with cirrhosis
por: Guo, Yantong, et al.
Publicado: (2012)

Suppression of Heterogeneous Nuclear Ribonucleoprotein C Inhibit Hepatocellular Carcinoma Proliferation, Migration, and Invasion via Ras/MAPK Signaling Pathway
por: Hu, Jiejun, et al.
Publicado: (2021)

Prognostic impact of lactic dehydrogenase to albumin ratio in hepatocellular carcinoma patients with Child–Pugh I who underwent curative resection: a prognostic nomogram study [Erratum]
Publicado: (2018)

The homogeneity and heterogeneity of occurrence, characteristics, and prognosis in hepatocellular carcinoma patients with synchronous and metachronous bone metastasis
por: Zhang, Yanting, et al.
Publicado: (2022)

ERRATUM: A reduction in reactive oxygen species contributes to dihydromyricetin-induced apoptosis in human hepatocellular carcinoma cells
por: Liu, Bin, et al.
Publicado: (2015)

Impact of hepatocellular carcinoma heterogeneity on computed tomography as a prognostic indicator
por: Kiryu, Shigeru, et al.
Publicado: (2017)

Uncompromised Treatment Efficacy in Elderly Patients With Hepatocellular Carcinoma: A Propensity Score Analysis: Erratum
Publicado: (2015)

Transarterial embolization/chemoembolization therapy for hepatocellular carcinoma fed by adrenal artery: Preliminary results: Erratum
Publicado: (2017)

Erratum to “Immunotherapy in hepatocellular carcinoma: evaluation and management of adverse events associated with atezolizumab plus bevacizumab”
Publicado: (2021)

Erratum to “Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway”
por: Huang, Lu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4iq4190sk56ns4a908dihvg85h